The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a detailed analysis of its phase III REGENCY trial of Gazyva®/Gazyvaro® (obinutuzumab) in people with active lupus nephritis (LN) was published ...

Mass General Brigham researchers discovered a previously unknown mechanism that may drive tissue damage and a new target for drug discovery ...

In a new study, researchers at Case Western Reserve University School of Medicine have determined that a protein called NF-kB c-Rel can intensify the condition’s symptoms when activated by signals ...

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...

1 Department of Clinical Immunology, University Hospital, Groningen, The Netherlands 2 Department of Rheumatology, University Hospital, Groningen, The Netherlands 3 Department of Pathology ... int.azg ...

A woman in her 30s with no medical or family history was diagnosed with systemic lupus erythematosus (SLE ... A skin biopsy was obtained, and pathology revealed diffuse infiltration of the dermis with ...

French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Paris, France 5 ...

Objective Metabolic reprogramming plays a critical role in modulating the innate and adaptive immune response, but its role in cutaneous autoimmune diseases, such as cutaneous lupus erythematosus ...

The pathologists at the Institute of Tissue Medicine and Pathology from the University of Bern described ... Differential diagnostics between pre-eclampsia (PE) and systemic lupus erythematosus (SLE) ...

Lupus can do irreversible harm to a person's organs, damaging the lungs, kidneys, heart, liver and other vital organs through ...